Effectiveness of High Definition-transcranial Direct Current Stimulation (HD-tDCS) on the mental health of elderly

Effectiveness of High Definition-transcranial Direct Current Stimulation (HD-tDCS) on Cognitive Problems and Mood of Shiraz Elderly

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190708044138N2

Enrollment

Registered

2020-05-18

Start date

2019-11-12

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder, single episode, moderate. Major depressive disorder, single episode, moderate

Interventions

Intervention 1: The intervention group received high definition-transcranial direct current stimulation (HD-tDCS) at 2 mA (positive or anode stimulation) over 10 consecutive sessions (25 minutes per s

Eligibility

Sex/Gender

All

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Gaining mild to moderate depression score (scores from 14to 30) in the Beck depression inventory Rejecting differential diagnosis of neuro-motor disorder by a neurologist and absence of neurological disorder Aged between 50 to 75 years Not suffering from cardiovascular disease, kidney disease and diabetes (getting information by asking from participants and get help from a physician) Not Smoking and not taking painkillers, sedatives and hypnotics.

Exclusion criteria

Exclusion criteria: Dissatisfaction to participate in the research Having a type of motor or cognitive disabilities that interferes working with computer Receiving simultaneous psychiatric treatment or other psychotherapies to relieve depression disorder History of seizure disorders in individuals having a pacemaker, having a metal object in the head and neck or any other obstacle to do electrical stimulation

Design outcomes

Primary

Measure	Time frame
Cognitive Symptoms. Timepoint: Cognitive Symptoms was measured at the beginning of the study (before the intervention), after the last treatment session, and 30 days (one month) after the last treatment session. Method of measurement: The Integrated Visual and Auditory (IVA-2).;Depression. Timepoint: Depression was measured at the beginning of the study (before the intervention), after the last treatment session, and 30 days (one month) after the last treatment session. Method of measurement: Beck depression inventory (BDI-II).	—

Measure

Time frame

Cognitive Symptoms. Timepoint: Cognitive Symptoms was measured at the beginning of the study (before the intervention), after the last treatment session, and 30 days (one month) after the last treatment session. Method of measurement: The Integrated Visual and Auditory (IVA-2).;Depression. Timepoint: Depression was measured at the beginning of the study (before the intervention), after the last treatment session, and 30 days (one month) after the last treatment session. Method of measurement: Beck depression inventory (BDI-II).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Sorbi

Urmia University

Sorbih@gmail.com+98 44 3275 2741

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026